2023
DOI: 10.1007/s00044-023-03136-5
|View full text |Cite
|
Sign up to set email alerts
|

Bio-evaluation of the 2-nitrochalcones as potential anti-lung cancer agents, inducers of apoptosis and inhibitors of protein kinase (VEGFR-2)

Malose J. Mphahlele,
Garland K. More,
Marole M. Maluleka
et al.

Abstract: A series of the 2-nitrochalcones 3a–3k was synthesized and evaluated for cytotoxicity against the human lung adenocarcinoma (A549) and human embryonic kidney (HEK293-T) cell lines using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The 3-(4-fluorophenyl) 3c and the 3-(4-(1,1,2,2-tetrafluoroethoxy)phenyl derivative 3k induced early (25–29%) and late (48–60%) apoptosis of A549 cells as determined by the Annexin V-FITC/PI method. The 3-(4-fluorophenyl) 3c, 3-(4-methoxyphenyl) 3h, 3… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 50 publications
0
1
0
Order By: Relevance
“…[25] Concerning the nitro chalcones, an increase in the interactions with the protein residues in the VEGFR-2 active site was detected when the nitro group was present in the α,β-unsaturated carbonyl system. [26] Some pyrazole chalcones were reported to be effective against HELA and MCF-7 cancer cells, [27] whereas pyrazole-based chalcones 7 and 8 were effective against leukaemia cell lines. [28,29] Chalcones can suppress cancer cells through a variety of methods, including tubulin inhibition, [30] cyclin-dependent kinase (CDK(, [31] vascular endothelial growth factor receptor-2 (VEGFR-2), [32] epidermal growth factor receptor (EGFR), [33] glycogen synthase kinase 3 beta (GSK3β), [34] and mitogen-activated protein kinase (MAPK), [35] which is a common serine and threonine protein kinase found in eukaryotes, [36] and is critical for conveying extracellular stimuli into cells and inducing biological responses that can impact cell proliferation, differentiation, apoptosis, inflammation, and other processes.…”
Section: Introductionmentioning
confidence: 99%
“…[25] Concerning the nitro chalcones, an increase in the interactions with the protein residues in the VEGFR-2 active site was detected when the nitro group was present in the α,β-unsaturated carbonyl system. [26] Some pyrazole chalcones were reported to be effective against HELA and MCF-7 cancer cells, [27] whereas pyrazole-based chalcones 7 and 8 were effective against leukaemia cell lines. [28,29] Chalcones can suppress cancer cells through a variety of methods, including tubulin inhibition, [30] cyclin-dependent kinase (CDK(, [31] vascular endothelial growth factor receptor-2 (VEGFR-2), [32] epidermal growth factor receptor (EGFR), [33] glycogen synthase kinase 3 beta (GSK3β), [34] and mitogen-activated protein kinase (MAPK), [35] which is a common serine and threonine protein kinase found in eukaryotes, [36] and is critical for conveying extracellular stimuli into cells and inducing biological responses that can impact cell proliferation, differentiation, apoptosis, inflammation, and other processes.…”
Section: Introductionmentioning
confidence: 99%